Chronic pain and continuity of analgesic treatment during the COVID-19 pandemic.
Pain Pract
; 23(4): 359-367, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2305111
ABSTRACT
INTRODUCTION:
Chronic pain can trigger both physical and mental health complications. During the COVID-19 pandemic, patients with chronic diseases have had reduced access to some medications.OBJECTIVE:
To determine the pharmacological management of patients with chronic pain and its continuity during the COVID-19 pandemic.METHODS:
This was a retrospective longitudinal study of the continuity of analgesic use in patients with chronic pain between September 1, 2019 and February 28, 2021 based on a drug dispensing database. Survival analysis was performed until the discontinuation of chronic analgesics.RESULTS:
A total of 12,701 patients who were being treated for chronic pain were identified. Their median age was 70.3 years, and 74.4% were women. The pain of rheumatological origin was the most frequent etiology (46.1%); the most used medications were nonopioid analgesics (78.9%), pain modulators (24.8%) and opioid analgesics (23.3%). A total of 76.1% of the patients experienced interruptions in their management during the study period. The median time to the first interruption of treatment was 5.0 months (95% CI 4.8-5.2). Those who were treated for oncological pain experienced a greater number of interruptions in their management.CONCLUSIONS:
The pharmacological management of patients with chronic pain is heterogeneous, and this real-world study showed that a high proportion of patients experienced an interruption of pain management during the 12 months following the onset of the COVID-19 pandemic.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Dolor Crónico
/
COVID-19
Tipo de estudio:
Estudio de cohorte
/
Estudio de etiologia
/
Estudio observacional
/
Estudio pronóstico
Tópicos:
Covid persistente
Límite:
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Pain Pract
Asunto de la revista:
Neurología
/
Psicofisiología
Año:
2023
Tipo del documento:
Artículo
País de afiliación:
Papr.13197
Similares
MEDLINE
...
LILACS
LIS